Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Systemic Right Ventricles: Incrementally Building the Evidence Base
- PMID: 40439175
- PMCID: PMC12229210
- DOI: 10.1161/JAHA.125.043096
Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Systemic Right Ventricles: Incrementally Building the Evidence Base
Keywords: Editorials; congenital heart disease; heart failure; systemic right ventricle; transposition of the great arteries.
Conflict of interest statement
None.
Comment on
-
Safety and Efficacy of Dapagliflozin in Patients With Systemic Right Ventricular Dysfunction: DAPA-SRV Trial.J Am Heart Assoc. 2025 Jun 3;14(11):e040302. doi: 10.1161/JAHA.124.040302. Epub 2025 May 29. J Am Heart Assoc. 2025. PMID: 40439149 Free PMC article.
References
-
- Diller G‐P, Kempny A, Alonso‐Gonzalez R, Swan L, Uebing A, Li W, Babu‐Narayan S, Wort SJ, Dimopoulos K, Gatzoulis MA. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow‐up at a large tertiary Centre. Circulation. 2015;132:2118–2125. doi: 10.1161/CIRCULATIONAHA.115.017202 - DOI - PubMed
-
- Bruaene AVD, Hickey EJ, Kovacs AH, Crean AM, Wald RM, Silversides CK, Redington AN, Ross HJ, Alba AC, Billia F, et al. Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure. Int J Cardiol. 2018;252:80–87. doi: 10.1016/j.ijcard.2017.10.086 - DOI - PubMed
-
- van Dissel AC, Opotowsky AR, Burchill LJ, Aboulhosn J, Grewal J, Lubert AM, Antonova P, Shah S, Cotts T, John AS, et al. End‐stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study. Eur Heart J. 2023;44:3278–3291. doi: 10.1093/eurheartj/ehad511 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources